Page last updated: 2024-11-05

tiopronin and Inflammatory Bowel Diseases

tiopronin has been researched along with Inflammatory Bowel Diseases in 1 studies

Tiopronin: Sulfhydryl acylated derivative of GLYCINE.

Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, SH1
Shah, YM1
Inoue, J1
Morimura, K1
Kim, I1
Yim, S1
Lambert, G1
Kurotani, R1
Nagashima, K1
Gonzalez, FJ1
Inoue, Y1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effect of Palmitoleic Acid (FAn-7) on Expression of HNF4γ and Ulcerative Colitis (UC) Activity[NCT01771224]Early Phase 120 participants (Anticipated)Interventional2013-01-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for tiopronin and Inflammatory Bowel Diseases

ArticleYear
Hepatocyte nuclear factor 4alpha in the intestinal epithelial cells protects against inflammatory bowel disease.
    Inflammatory bowel diseases, 2008, Volume: 14, Issue:7

    Topics: Adult; Aged; Animals; Aquaporins; Blotting, Northern; Blotting, Western; Colitis, Ulcerative; Colon;

2008